Vascular cognitive impairment

被引:119
作者
Selnes, Ola A.
Vinters, Harry V.
机构
[1] Johns Hopkins Univ, Sch Med, Div Cognit Neurosci, Dept Neurol, Baltimore, MD 21205 USA
[2] Johns Hopkins Univ, Sch Med, Dept Psychiat, Baltimore, MD 21205 USA
[3] Univ Calif Los Angeles, Los Angeles, CA USA
来源
NATURE CLINICAL PRACTICE NEUROLOGY | 2006年 / 2卷 / 10期
关键词
brain ischemia; CADASIL; cerebral amyloid angiopathy; cerebrovascular disorders; dementia;
D O I
10.1038/ncpneuro0294
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Cognitive impairment commonly accompanies clinical syndromes associated with vascular disease of the brain. Because of evolving definitional criteria, however, the frequency of cognitive impairment attributable to cerebrovascular disease is difficult to determine. Dementia occurs in up to one-third of elderly patients with stroke, a subset of whom have Alzheimer's disease (AD) rather than a pure vascular dementia syndrome. In fact, pure vascular dementia has been shown to be uncommon in most large autopsy series. A mixed etiology of AD and cerebrovascular disease is thought to become more common with increasing age, although no clinical criteria for the diagnosis of AD with cerebrovascular disease are currently available. Epidemiological studies have implicated subcortical small-vessel disease as a risk factor for cognitive impairment and dementia, but the cognitive expression and clinical significance of MRI white matter changes in individual patients is difficult to establish. The frequency of specific neuropathologic features of vascular cognitive impairment depends largely on study inclusion criteria. Cerebral meningocortical microangiopathies with distinctive clinicopathological profiles are associated with dementia in both sporadic cases and familial syndromes. In patients with AD, the contribution of amyloid-beta protein to the degree of cognitive impairment has not been clearly defined.
引用
收藏
页码:538 / 547
页数:10
相关论文
共 88 条
[1]   Giant cell arteritis in association with cerebral amyloid angiopathy: Immunohistochemical and molecular studies [J].
Anders, KH ;
Wang, ZZ ;
Kornfeld, M ;
Gray, F ;
Soontornniyomkij, V ;
Reed, LA ;
Hart, MN ;
Menchine, M ;
Secor, DL ;
Vinters, HV .
HUMAN PATHOLOGY, 1997, 28 (11) :1237-1246
[2]   Cortical and subcortical diseases: Do true neuropsychological differences exist? [J].
Arango-Lasprilla, JC ;
Rogers, H ;
Lengenfelder, J ;
DeLuca, J ;
Moreno, S ;
Lopera, F .
ARCHIVES OF CLINICAL NEUROPSYCHOLOGY, 2006, 21 (01) :29-40
[3]   Poststroke dementia -: Clinical features and risk factors [J].
Barba, R ;
Martínez-Espinosa, S ;
Rodríguez-García, E ;
Pondal, M ;
Vivancos, J ;
Del Ser, T .
STROKE, 2000, 31 (07) :1494-1501
[4]   The concept of vascular cognitive impairment [J].
Bowler, JV .
JOURNAL OF THE NEUROLOGICAL SCIENCES, 2002, 203 :11-15
[5]  
Brown WR, 2000, AM J NEURORADIOL, V21, P79
[6]   Cognitive profile in CADASIL [J].
Buffon, F ;
Porcher, R ;
Hernandez, K ;
Kurtz, A ;
Pointeau, S ;
Vahedi, K ;
Bousser, MG ;
Chabriat, H .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2006, 77 (02) :175-180
[7]   Cerebral beta amyloid angiopathy is a risk factor for cerebral ischemic infarction. A case control study in human brain biopsies [J].
Cadavid, D ;
Mena, E ;
Koeller, K ;
Frommelt, RA .
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2000, 59 (09) :768-773
[8]  
Chabriat Hugues, 2003, Adv Neurol, V92, P147
[9]   Neuropathology lessons in vascular dementia [J].
Chui, H .
ALZHEIMER DISEASE & ASSOCIATED DISORDERS, 2005, 19 (01) :45-52
[10]  
de Groot JC, 2000, ANN NEUROL, V47, P145